Competitive Cancer Vaccine technology
Our Vaccines induce the highest levels of immune response (CD4+ , CD8+, antibodies, innate immunity)
Adenoviral vectors
- Superiority to other genetic vectors (DNA and viral)
- Lower prevalence Ad serotypes
Muscle Electro-gene-transfer
- Unlimited potential
- Pioneering work of our group in the field
Design Protein/Peptide vaccines
- Modifications with enhanced immunogenicity